CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Revenues	$ 1,604,354	$ 1,054,312
Expenses:
General and administrative (including noncash stock-based compensation expense of $16,909 and $13,585, respectively)	76,422	69,752
Depreciation and amortization	5,844	2,954
Total expenses	1,611,532	1,053,895
Income (loss) from operations	(7,178)	417
Other income (expense):
Income (loss) from equity method investments	5,684	1,376
Other income (expense), net	5,892	7,892
Interest expense	(1,284)	(1,493)
Income (loss) before income taxes	3,114	8,192
Income tax benefit (expense)	133	1,759
Income (loss) from continuing operations	3,247	9,951
Discontinued operations:
Income (loss) before gain (loss) on sales	(518)	6,008
Gain (loss) on sales of assets, net	(8,763)	0
Total discontinued operations	(9,281)	6,008
Net income (loss)	(6,034)	15,959
Noncontrolling interests’ share in (earnings) loss	(30)	63
Net income (loss) attributable to common shares	$ (6,064)	$ 16,022
Net income (loss) per common share, basic and diluted
Continuing operations, basic (in dollars per share)	$ 0.01	$ 0.02
Continuing operations, diluted (in dollars per share)	0.01	0.02
Discontinued operations, basic (in dollars per share)	(0.02)	0.02
Discontinued operations, diluted (in dollars per share)	$ (0.02)	$ 0.02
Weighted average shares outstanding
Basic (in shares)	408,938	413,136
Diluted (in shares)	413,437	426,586
Medical services revenue
Revenues:
Revenues	$ 1,601,195	$ 1,053,119
Expenses:
Expenses	1,443,842	897,572
Other operating revenue
Revenues:
Revenues	3,159	1,193
Expenses:
Expenses	$ 85,424	$ 83,617